2 results
Not approvedWill not start
The primary objective of this study is to demonstrate that the IOP-lowering efficacy of Travoprost Ophthalmic Solution, 0.004% (preserved with POLYQUAD) is noninferior to Timolol Ophthalmic Solution (0.5% or 0.25%) in pediatric glaucoma patients.
Approved WMOCompleted
Primary Objective 1:Verfiy that energy can be transmitted from an external unit to the NSM AHLeveeS System, through a wireless connection, resulting in stimulation of the S3 sacral nerve.Primary Objective 2:Confirm that the NSM AHLeveeS System can…